Novartis will donate enough doses of malaria drug hydroxychloroquine to treat se...
FILE PHOTO: The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann
There are no vaccines or treatments approved for the disease, but there is currently a 1,500-person trial, led by the University of Minnesota, to see whether hydroxychloroquine can prevent or reduce the severity of COVID-19. Two other trials are studying blood pressure drug losartan as a possible treatment.
“Novartis is supporting ongoing clinical trial efforts, and will evaluate needs for additional clinical trials,” it said in a statement. The American Society of Health-System Pharmacists , added hydroxychloroquine to its list of drugs in short supply this week. Four out of eight manufacturers of the drug are in short supply, it said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
'Race against the clock': Scientists testing if existing drugs can fight novel coronavirus right nowDozens of already-existing drugs may be able to treat the novel coronavirus.
続きを読む »
Trump directs FDA to examine whether malaria drug can be used for coronavirusThe novel coronavirus, which is believed to have originated in the Chinese city of Wuhan, has rapidly spread around the world, infecting more than 219,000 people and killing at least 8,900.
続きを読む »
Joe: Trump's 'big' coronavirus FDA news is yet another 'overpromise'Joe Scarborough comments on the president's latest briefing on the coronavirus outbreak, calling the announcement of using a malaria drug for treatment another 'overpromise' from the administration.
続きを読む »
Chloroquine, an old malaria drug, may help treat novel coronavirus, doctors sayWhat do malaria and COVID-19 have in common? On the surface, not much. But according to early research, an old malaria drug called chloroquine might also work for the new coronavirus.
続きを読む »
Here are 3 drugs in development to fight coronavirus, 2 vaccines and one 'passive' vaccineMany companies are working on vaccines, but these are the three that experts say are closest to being tested, approved and available to the U.S. public.
続きを読む »